Login
Toggle navigation
Videos
Categories
Trending
David Gandler, CEO of Fubo TV, discusses the impact of the merger between competitors DISH and DirecTV on 'Closing Bell'.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
David Gandler is Co-founder and CEO of FuboTV Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:00:00
Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress - Lisa Anson Chief Executive Officer, Redx Pharma
00:10:00
Instem PLC's CEO Phil Reason discusses the company's robust 2022 financial performance, marked by a 28% revenue growth, 32% increase in underlying earnings, and anticipated benefits from industry consolidation in 2023, alongside recent successes such as h
00:10:00
Early-stage VC fund investing in tech that improves|Maria (Toler) Velissaris,Founding and Managing Partner,SteelSky Ventures
00:10:00
Greg Foran at IATA AGM 2022: Insights from Air New Zealand’s CEO | Greg Foran, CEO, Air New Zealand Ltd .
00:10:00
Navigating Economic Waters: Q2 Market Update 2022 | Jason Gunkel, Chief Investment Officer, Financial Planner of Syverson Strege
00:10:00
Jim Russo on Market Selloff Amid Omicron Fears, Inflation, and Fed Comments | James M. Russo , Founder , Altrius Capital Management Inc.
00:10:00
Governance Voice: Insights on CEO Succession and Board Evaluations with Beverly Beaudoin
00:10:00
"Entrepreneurial Journey: Catalina Aguirre and Kumiko's Rise in Cosmetics"
00:10:00
Financial Planner & Real Estate Investor: Meghan Chomut
00:10:00
Extraordinary Diamond Recoveries Propel Momentum for Johnny's Mines at One-to-One Conference
00:10:00
Outstanding Overseas Executive Of The Year|David Su,managing partner,Matrix Partners China
00:10:00
Culpeo Minerals Strikes 169-Metre Copper Intersection at Lana Corina in Chile's Atacama Desert | Max Tuesley, Managing Director , Culpeo Mineral Plc.